Top Markets
Coin of the day
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock

Polaryx Therapeutics, Inc. Common Stock

PLYX
Classificação em ações #21586
Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to... Polaryx Therapeutics, Inc. functions as a biotechnology firm dedicated to advancing small-molecule therapies for lysosomal storage and neurodegenerative conditions. Its developmental pipeline includes a trio of promising candidates: PLX-100, which combines PLX-200 with an ancillary supplement, targeting late infantile neuronal ceroid lipofuscinosis (LINCL) and related forms of NCL. PLX-200, a repurposed compound already utilized to address various diseases in both adult and pediatric populations. And PLX-300, derived from an edible plant, which works by activating PPARa to enhance the production of transcription factor EB. The company, established in 2014, maintains its base of operations in Paramus, New Jersey.
Preço da ação
$2.10
Última sincronização: 2026-08-21
Valor de mercado
$104.43M
Variação (1 dia)
-2.10%
Variação (1 ano)
-
País
US
Negociar Polaryx Therapeutics, Inc. Common Stock (PLYX)

Categoria

Preço PLYX com a capitalização de mercado de B
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
PLYX
$2.10
Capitalização de mercado de Polaryx Therapeutics, Inc. Common Stock(PLYX)
Valor de mercado: $104.43M
Em August 2026, Polaryx Therapeutics, Inc. Common Stock tem uma capitalização de mercado de $104.43M. Isso faz com que Polaryx Therapeutics, Inc. Common Stock seja a 21586th empresa mais valiosa do mundo em termos de capitalização de mercado, de acordo com os nossos dados. A capitalização de mercado, também chamada de market cap, é o valor total de mercado das ações em circulação de uma empresa de capital aberto e é amplamente utilizada para medir o valor de uma empresa.
Histórico de capitalização de mercado de Polaryx Therapeutics, Inc. Common Stock de 2026 a 2026
PLYX comparado com o topo de 5 mais populares stocks
Preço para PLYX Ativo B Capitalização de mercado de B Resultados
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$104,550 $104.43M
$5.211T +4,990,345.79%
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$91,216.26 $104.43M
$4.547T +4,353,897.93%
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$83,507.08 $104.43M
$4.162T +3,985,918.08%
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$72,078.12 $104.43M
$3.593T +3,440,383.24%
Polaryx Therapeutics, Inc. Common Stock Polaryx Therapeutics, Inc. Common Stock
$56,029.90 $104.43M
$2.793T +2,674,358.16%